SEC Form 5 · accession 0000899243-16-013409
Sucampo Pharmaceuticals, Inc. · SCMP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ryuji Ueno
10% Owner
Period of report
Dec 31, 2015
Accepted (ET)
Feb 16, 2016 · 6:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common StockF1 | Aug 27, 2015 | G | 2,000,000 | $0.00 | D | 18,274,689 | I | By S&R Technology Holdings, LLC |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1S&R Technology Holdings, LLC is wholly owned by Dr. Ueno and his wife. Dr. Ueno disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein.